Legal & General Group Plc Cuts Stock Holdings in Masimo Corporation $MASI

by · The Markets Daily

Legal & General Group Plc trimmed its holdings in shares of Masimo Corporation (NASDAQ:MASI – Free Report) by 10.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 92,436 shares of the medical equipment provider’s stock after selling 10,241 shares during the period. Legal & General Group Plc owned about 0.17% of Masimo worth $12,022,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Global Retirement Partners LLC purchased a new stake in Masimo during the fourth quarter valued at about $27,000. Torren Management LLC purchased a new stake in Masimo during the fourth quarter valued at about $35,000. Smartleaf Asset Management LLC boosted its position in Masimo by 80.0% during the third quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 136 shares during the period. Advisory Services Network LLC purchased a new stake in Masimo during the third quarter valued at about $46,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new stake in Masimo during the fourth quarter valued at about $44,000. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts have issued reports on MASI shares. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a report on Tuesday, February 17th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a report on Wednesday, March 18th. Finally, BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $180.40.

Check Out Our Latest Stock Report on Masimo

Masimo Price Performance

MASI stock opened at $178.78 on Thursday. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.00. The company has a market cap of $9.36 billion, a P/E ratio of -16.96, a PEG ratio of 1.81 and a beta of 1.11. The firm has a 50-day moving average of $178.43 and a 200 day moving average of $158.99. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.45.

Masimo Profile

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Featured Articles